The Clorox Company (NYSE:CLX) Shares Sold by TIAA Trust National Association

TIAA Trust National Association lessened its position in shares of The Clorox Company (NYSE:CLX) by 5.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,736 shares of the company’s stock after selling 354 shares during the quarter. TIAA Trust National Association’s holdings in Clorox were worth $783,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. SG Americas Securities LLC grew its position in shares of Clorox by 1,525.7% in the first quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock valued at $10,046,000 after purchasing an additional 61,576 shares during the period. Mizuho Markets Americas LLC grew its position in shares of Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock valued at $11,032,000 after purchasing an additional 34,864 shares during the period. CANADA LIFE ASSURANCE Co grew its position in shares of Clorox by 15.2% in the first quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock valued at $21,705,000 after purchasing an additional 18,687 shares during the period. Advisors Asset Management Inc. grew its position in shares of Clorox by 257.5% in the first quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock valued at $1,719,000 after purchasing an additional 8,087 shares during the period. Finally, Game Plan Financial Advisors LLC acquired a new stake in shares of Clorox in the first quarter valued at about $1,025,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Trading Up 0.4 %

NYSE CLX opened at $164.77 on Friday. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $165.71. The stock has a market capitalization of $20.46 billion, a P/E ratio of 85.37, a PEG ratio of 3.21 and a beta of 0.39. The firm’s 50-day moving average is $142.37 and its two-hundred day moving average is $142.82. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. On average, sell-side analysts anticipate that The Clorox Company will post 6.56 earnings per share for the current year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were paid a $1.22 dividend. The ex-dividend date of this dividend was Tuesday, August 13th. This is a boost from Clorox’s previous quarterly dividend of $1.20. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.96%. Clorox’s payout ratio is presently 252.85%.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on CLX shares. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research note on Friday, August 2nd. DA Davidson cut their price target on Clorox from $162.00 to $153.00 and set a “neutral” rating for the company in a report on Friday, August 2nd. BNP Paribas started coverage on Clorox in a research report on Monday, June 24th. They set an “underperform” rating and a $130.00 price objective on the stock. Citigroup upped their target price on Clorox from $145.00 to $165.00 and gave the company a “neutral” rating in a report on Wednesday, August 28th. Finally, TD Cowen initiated coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target on the stock. Six investment analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to data from MarketBeat, Clorox has a consensus rating of “Hold” and an average price target of $143.19.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.